These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1318205)

  • 1. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
    Small DL; Bolzon BJ; Cheung DW
    Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
    Prieto D; Simonsen U; Nyborg NC
    Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
    García-Villalón AL; Padilla J; Fernández N; Monge L; Martínez MA; Gómez B; Diéguez G
    Pflugers Arch; 2000 Aug; 440(4):548-55. PubMed ID: 10958338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
    Andriantsitohaina R; Stoclet JC
    Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation by the endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery.
    Thorin E; Atkinson J
    Br J Pharmacol; 1994 Jan; 111(1):351-7. PubMed ID: 8012718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit.
    Gustafsson H; Nilsson H
    Acta Physiol Scand; 1990 Apr; 138(4):503-7. PubMed ID: 2353579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective potentiation of extracellular Ca2+-dependent contraction by neuropeptide Y in rabbit mesenteric arteries.
    Oshita M; Kigoshi S; Muramatsu I
    Gen Pharmacol; 1989; 20(3):363-7. PubMed ID: 2545512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelium on the effects of neuropeptide Y in mesenteric resistance arteries of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Andriantsitohaina R; Stoclet JC; Bukoski RD
    J Pharmacol Exp Ther; 1991 Apr; 257(1):276-81. PubMed ID: 2019991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
    Bradley E; Law A; Bell D; Johnson CD
    Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2007-14. PubMed ID: 12742824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism.
    Fallgren B; Arlock P; Edvinsson L
    J Auton Nerv Syst; 1993; 44(2-3):151-9. PubMed ID: 8227954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y potentiates specifically the purinergic component of the neural responses in the guinea pig saphenous artery.
    Cheung DW
    Circ Res; 1991 May; 68(5):1401-7. PubMed ID: 2018998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
    Pernow J; Svenberg T; Lundberg JM
    Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
    Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melatonin in the rat tail artery: role of K+ channels and endothelial factors.
    Geary GG; Duckles SP; Krause DN
    Br J Pharmacol; 1998 Apr; 123(8):1533-40. PubMed ID: 9605558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium removal does not affect potentiation by neuropeptide Y in rabbit ear artery.
    Budai D; Vu HQ; Duckles SP
    Eur J Pharmacol; 1989 Sep; 168(1):97-100. PubMed ID: 2583236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
    Adamsson M; Fallgren B; Edvinsson L
    Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the selectivity of alpha, beta-methylene ATP in inhibiting vascular responses of the rat in vivo and in vitro.
    Dalziel HH; Gray GA; Drummond RM; Furman BL; Sneddon P
    Br J Pharmacol; 1990 Apr; 99(4):820-4. PubMed ID: 1972897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.
    Prieto D; Benedito S; Simonsen U; Nyborg NC
    Br J Pharmacol; 1991 Mar; 102(3):754-8. PubMed ID: 1364848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.